Promoting endothelialization of flow-diverting stents: a review
- PMID: 32487770
- DOI: 10.1136/neurintsurg-2020-015874
Promoting endothelialization of flow-diverting stents: a review
Abstract
Intracranial flow-diverting (FD) stents have revolutionized the treatment of intracranial aneurysms in recent years, but complications resulting from failed endothelialization can still occur. Approaches to promote endothelialization are understudied, but hold promise in mitigating both short- and long-term complications associated with FD stent insertion. The aim of this review is to highlight the various features of and modifications that have been made to FD stents in order to expedite endothelialization. More specifically, we focus on how endothelialization can be influenced by the stent design, wall apposition, surface modifications, and the inclusion of biological agents.
Keywords: aneurysm; bioactive; flow diverter; stent; stroke.
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: APM reports being a shareholder and co-founder of Fluid Biotech Inc., during the conduct of the study; personal fees from Cerus Endovascular, grants from Stryker Neurovascular, personal fees from Microvention, outside the submitted work; in addition, APM has a patent PCT/CA2019/050304 pending to Fluid Biotech Inc.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical